Company page

Stemcell Institute

Stemcell Institute, traded under the ticker 7096, is a public company operating in Japan with a market capitalization of approximately 42 million USD. The company focuses on advancements in stem cell research and applications. Its commitment to innovative solutions positions it as a key player in the biotechnology sector.